Latest Headlines

  1. American Cancer Society Recommends Guardant Health's Shield Blood Test In Updated Colorectal Cancer Screening Guidelines 5/27/2026

    Guardant Health, Inc. a leading precision oncology company, announced that its FDA-approved Shield blood test is now included in updated American Cancer Society (ACS) Colorectal Cancer (CRC) Screening Guidelines published today.

  2. CPC Biotech Collaborates With Multiply Labs To Advance Cell Therapy Automation 5/27/2026

    CPC Biotech, part of PSG and Dover (NYSE: DOV) and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceutical processing, has collaborated with Multiply Labs to rapidly advance the use of robotic systems in cell therapy manufacturing.

  3. FDA Breakthrough Device Designation Marks Major Milestone For Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test 5/27/2026

    Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to SPOT-MAS 10, its multi-omic blood test designed to detect cancer-associated signals.

  4. Argonne Launches First Large-Scale AI Inference Service For Open Science 5/27/2026

    The U.S. Department of Energy’s (DOE) Argonne National Laboratory has launched a first-of-its-kind AI inference service to help researchers across the nation accelerate discovery and innovation.

  5. TOBY Receives FDA Breakthrough Device Designation For Its Urine-Based Alzheimer's Disease Diagnostic Test 5/26/2026

    TOBY, Inc., a biotechnology company developing non-invasive disease detection technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the TOBY Test for Alzheimer's Disease.

  6. Umbrella Lab Announces Documentation And Traceability Update For Epitalon Peptide 5/25/2026

    Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for epitalon peptide reference material, provided strictly for laboratory developmental research use only

  7. Labcorp Launches MyLabcorp™, A New AI-Powered Mobile App Designed To Help Consumers Understand Lab Results And Track Health Trends Over Time 5/20/2026

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of MyLabcorp™, an AI-powered mobile app that brings together lab results, AI-enabled features and clinical guideline-based content in a secure, personalized mobile experience.

  8. Umbrella Lab Announces Documentation And Traceability Update For Dihexa Peptide 5/19/2026

    Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for dihexa peptide reference material, provided strictly for laboratory developmental research use only.

  9. NGI Becomes First Certified Core Lab And Service Provider For Epigenica's EpiFinder Platforms 5/19/2026

    Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced an agreement with the National Genomics Infrastructure (NGI), one of the largest technical platforms at SciLifeLab.

  10. Safety Without Compromise: IKA Launches The Next Evolution Of Magnetic Stirring 5/19/2026

    IKA’s new generation of magnetic stirrers incorporates state-of-the-art smart features, setting the new global standards for efficiency, safety, and reliability.